VPS35 and Parkinson disease: Thus, the endogenous expression of VPS35–D620N is sufficient to recapitulate some features of PD pathology inducing (i) the progressive degeneration of the nigrostriatal pathway, (ii) modest motor deficit with age consistence, and (iii) widespread axonal damage (43).